DePuy Synthes, Pacira partner on Exparel education: 5 key notes

Spinal Tech

Pacira Pharmaceuticals partnered with DePuy Synthes Sales to market the company's bupivacaine liposome injectable suspension Exparel for orthopedic surgeries in the United States.

Here are five key notes:


1. Under the agreement, DePuy Synthes field representatives will collaborate with and supplement the Pacira field teams with Exparel education in the hospital surgical suite and ASC.


2. Pacira will focus on soft tissue surgeons in addition to supporting DePuy Synthes' efforts with joint reconstruction, spine, sports medicine and trauma surgeons.


3. Pacira will remain the overall Exparel account manager.


4. The collaboration expands Pacira's marketing and educational activities as well as tailors their material to specific patient groups.


5. Pacira expects to report key Exparel data sets in orthopedic procedures this year.


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers